Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probe.
Freeberg JA, Serachitopol DM, McKinnon N, Price R, Atkinson EN, Cox DD, MacAulay C, Richards-Kortum R, Follen M, Pikkula B. J Biomed Opt. 2007 May-Jun; 12(3):034015.